Henrik Winther
DVM, PhD
SVP Business Development since 2020
SVP Business Development since 2020
Henrik has 20+ years of experience in the in vitro diagnostic (IVD) industry bringing biomarker assays into global clinical use and managing roles within R&D and Business Development.
Henrik has a special passion for Companion Diagnostics (CDx) and has held General Manager roles in the Companion Diagnostics field and in collaborations with Pharma at Dako and Agilent Technologies. He was responsible for the first global CDx assay (HercepTestTM/Dako) and later for the development, registration, and commercialization of both the Keytruda CDx and the Opdivo CDx (one true CDx and the other a Complementary Diagnostic).